Tag

Takeover Talks

All articles tagged with #takeover talks

Macy's Ends Buyout Talks, Stock Plummets 12%
business1 year ago

Macy's Ends Buyout Talks, Stock Plummets 12%

Macy's has ended its takeover discussions with Arkhouse Management and Brigade Capital Management due to an unsatisfactory offer and uncertainty over financing. The investment firms failed to provide necessary information by the deadline, and their proposal was deemed "not compelling." Macy's shares fell 14.5% following the announcement. The company will now focus on its own turnaround strategy, which includes closing stores, upgrading remaining locations, and expanding luxury and small-format stores. Macy's recent financial results showed some positive signs, beating Wall Street expectations.

"Boeing in Talks to Reacquire Spirit AeroSystems, 737 Max Supplier"
business1 year ago

"Boeing in Talks to Reacquire Spirit AeroSystems, 737 Max Supplier"

Boeing is in talks to take over Spirit Aerosystems, a major global air parts supplier that was spun out of Boeing in 2005. The potential takeover comes as Boeing faces pressure over manufacturing issues, including a recent incident where a piece of one of its planes blew off in mid-air. The US government's review found that bolts meant to fasten the panel had been removed at Boeing's factory in Washington, apparently to fix damaged rivets, and had never been re-installed. Boeing believes that reintegration with Spirit would strengthen aviation safety and improve quality. Following reports of takeover talks, shares in Spirit jumped by more than 10%, while shares in Boeing slid more than 1%.

Novartis in Talks to Acquire MorphoSys, Karyopharm Surges in Sympathy
finance1 year ago

Novartis in Talks to Acquire MorphoSys, Karyopharm Surges in Sympathy

MorphoSys AG's ADRs surged 58% following reports of advanced takeover talks with Novartis, potentially edging out a rival bid from Incyte. The cancer drugmaker has attracted interest from three large pharmaceutical companies, with two based in Europe and one in the U.S. Karyopharm Therapeutics also saw a 37% surge in sympathy with the news, as analysts anticipate potential readthrough and continued upside for the company amidst the takeover speculation.